Bioinformatics and Information Technologies

生物信息学和信息技术

基本信息

项目摘要

PROJECT SUMMARY (See instructions): Core L - Scientific inquiry and public health are being fundamentally changed by immense volumes of complex data, and modern computational techniques that are able to mine these data for pattern discovery and inference. The field of HIV research is no exception, and many innovative discoveries have been facilitated or validated by sophisticated modeling and data analyses. Traditional biostatistics services are neither designed to handle gigantic volumes of complex data, nor are these new data types (e.g., next generation sequencing data) a natural fit for current computational biology and informatics applications. The purpose of the Bioinformatics and Information Technologies (BIT) is to handle CFAR investigator demand for storing, managing, analyzing, interpreting, and disseminating large and complex data sets, especially those containing viral and host molecular sequences. Based on ongoing and anticipated future needs of CFAR members, in the next five years, the BIT Core is structured as three interlinked units that will: (1) provide bioinformatics support for CFAR researchers by leveraging world-class expertise in bioinformatics and computational biology available at UCSD to offer a comprehensive spectrum of services and consultations related to computational analyses of data collected by CFAR investigators; (2) supply content management systems, web services for biomedical data, and computational infrastructure; and (3) provide training in bioinformatics and information technology. The BIT Core is uniquely positioned to provide these innovative services to CFAR members by drawing upon cutting edge in-house methodological research, modern sequencing and biomedical technologies offered by other CFAR Cores (e.g. GS, PEP, Flow Cytometry Cores), and professional software development and support expertise of its programming team. The CFAR External Advisory Committee reviewed our Center in February, 2012 and noted the following about the BIT Core in their final report: "The BIT Core is likely to set the standard for how CFARs handle next generation sequencing analysis, cohort data management and provide web presence."
项目摘要(参见说明):核心 L - 大量复杂数据以及能够挖掘这些数据以进行模式发现和推理的现代计算技术正在从根本上改变科学探究和公共卫生。 HIV 研究领域也不例外,许多创新发现都是通过复杂的建模和数据分析得到促进或验证的。传统的生物统计服务既不是为处理大量复杂数据而设计的,这些新数据类型(例如下一代测序数据)也不是当前计算生物学和信息学应用的自然选择。生物信息学和信息技术 (BIT) 的目的是满足 CFAR 研究人员对存储、管理、分析、解释和传播大型复杂数据集(尤其是包含病毒和宿主分子序列的数据集)的需求。根据 CFAR 成员持续和预期的未来需求,在未来五年内,BIT 核心由三个相互关联的单元组成,这些单元将:(1)利用 UCSD 提供的世界一流的生物信息学和计算生物学专业知识,为 CFAR 研究人员提供生物信息学支持,提供与 CFAR 研究人员收集的数据计算分析相关的全面服务和咨询; (2) 提供内容管理系统、生物医学数据网络服务和计算基础设施; (3) 提供生物信息学和信息技术培训。 BIT 核心具有独特的优势,通过利用其他 CFAR 核心(例如 GS、PEP、流式细胞术核心)提供的尖端内部方法学研究、现代测序和生物医学技术,以及其编程团队的专业软件开发和支持专业知识,为 CFAR 成员提供这些创新服务。 CFAR 外部咨询委员会于 2012 年 2 月审查了我们的中心,并在其最终报告中指出了有关 BIT 核心的以下内容:“BIT 核心可能会为 CFAR 如何处理问题设定标准。 下一代测序分析、队列数据管理并提供网络展示。”

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DOUGLAS D RICHMAN其他文献

DOUGLAS D RICHMAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DOUGLAS D RICHMAN', 18)}}的其他基金

Measuring the Latent Reservoir and Monitoring Eradication Strategies
测量潜在储库并监测根除策略
  • 批准号:
    8326895
  • 财政年份:
    2011
  • 资助金额:
    $ 2.85万
  • 项目类别:
Gene expression biomarkers of immune recovery in HIV infected patients
HIV感染者免疫恢复的基因表达生物标志物
  • 批准号:
    8591371
  • 财政年份:
    2009
  • 资助金额:
    $ 2.85万
  • 项目类别:
Gene expression biomarkers of immune recovery in HIV infected patients
HIV感染者免疫恢复的基因表达生物标志物
  • 批准号:
    8389836
  • 财政年份:
    2009
  • 资助金额:
    $ 2.85万
  • 项目类别:
Targeting regulators of cellular gene transcription to impact HIV latency
靶向细胞基因转录调节因子以影响 HIV 潜伏期
  • 批准号:
    7860484
  • 财政年份:
    2009
  • 资助金额:
    $ 2.85万
  • 项目类别:
Targeting regulators of cellular gene transcription to impact HIV latency
靶向细胞基因转录调节因子以影响 HIV 潜伏期
  • 批准号:
    7554818
  • 财政年份:
    2009
  • 资助金额:
    $ 2.85万
  • 项目类别:
Southern California Primary Infection Program
南加州初级感染计划
  • 批准号:
    7931675
  • 财政年份:
    2009
  • 资助金额:
    $ 2.85万
  • 项目类别:
Developmental
发育性
  • 批准号:
    7635794
  • 财政年份:
    2008
  • 资助金额:
    $ 2.85万
  • 项目类别:
Transmission Correlates
传输相关性
  • 批准号:
    8375407
  • 财政年份:
    2008
  • 资助金额:
    $ 2.85万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    7694181
  • 财政年份:
    2008
  • 资助金额:
    $ 2.85万
  • 项目类别:
Administrative Core, Part 1
行政核心,第 1 部分
  • 批准号:
    7278943
  • 财政年份:
    2007
  • 资助金额:
    $ 2.85万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 2.85万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.85万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 2.85万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.85万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 2.85万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.85万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 2.85万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 2.85万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 2.85万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.85万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了